Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
I2S Micro Implantable Systems is a specialized neurotechnology company based in Salt Lake City, Utah, that focuses on the development and commercialization of high-performance implantable neural interface systems. The company was established in 2008 following its acquisition of the research products division of Cyberkinetics Neurotechnology Systems, which included the rights to the renowned Utah Array technology. I2S provides a comprehensive suite of tools for electrophysiological recording and stimulation, including the NeuroPort Array and the Cerebus data acquisition system, which are widely used by academic and clinical researchers to study brain function and develop brain-computer interfaces (BCIs). Closely affiliated with Blackrock Neurotech, I2S plays a pivotal role in advancing neuroprosthetic solutions for patients with spinal cord injuries, motor disabilities, and other neurological conditions. The company's technology is foundational to the field of neural engineering, enabling high-density, chronic recording of neural activity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on I2S Micro Implantable Systems.